Investor Notice: Robbins LLP Informs Investors of Class
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies...
Stay updated with breaking news from Case About. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies...
SAN DIEGO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise
Dada Nexus Limited (DADA) Allegedly Overstated its Revenues ...
SAN DIEGO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired AlloVir, Inc. (NASDAQ:ALVR)
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Mobileye Global Inc. securities between January 26,...